<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nontyphoidal Salmonella: Gastrointestinal infection and asymptomatic carriage</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nontyphoidal Salmonella: Gastrointestinal infection and asymptomatic carriage</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nontyphoidal Salmonella: Gastrointestinal infection and asymptomatic carriage</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elizabeth L Hohmann, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 10, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Salmonellae are motile gram-negative bacilli that infect or colonize a wide range of mammalian hosts. </p><p>Salmonellae cause a number of clinical infections in humans; these include:</p><p class="bulletIndent1"><span class="glyph">●</span>Gastroenteritis</p><p class="bulletIndent1"><span class="glyph">●</span>Enteric fever (systemic illness with fever and abdominal symptoms)</p><p class="bulletIndent1"><span class="glyph">●</span>Bacteremia and endovascular infection</p><p class="bulletIndent1"><span class="glyph">●</span>Focal metastatic infections such as osteomyelitis or abscess</p><p class="bulletIndent1"><span class="glyph">●</span>An asymptomatic chronic carrier state</p><p></p><p>Enteric fever is caused by <em>Salmonella typhi</em> and <em>Salmonella paratyphi</em>; the pathogenesis, microbiology, epidemiology, clinical features, and treatment of these infections are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/2703.html" rel="external">"Pathogenesis of enteric (typhoid and paratyphoid) fever"</a> and  <a class="medical medical_review" href="/d/html/2708.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Epidemiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/2712.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Treatment and prevention"</a>.)</p><p><em>Salmonella</em> serotypes other than <em>Salmonella typhi</em> and <em>Salmonella paratyphi </em>are collectively known as nontyphoidal salmonellae. Issues related to the microbiology, epidemiology of nontyphoidal salmonellae are discussed separately. (See  <a class="medical medical_review" href="/d/html/2700.html" rel="external">"Pathogenesis of Salmonella gastroenteritis"</a> and  <a class="medical medical_review" href="/d/html/2683.html" rel="external">"Nontyphoidal Salmonella: Microbiology and epidemiology"</a>.)</p><p>Issues related to management of patients with nontyphoidal <em>Salmonella</em> in a stool culture will be reviewed here. Issues related to extraintestinal infection with nontyphoidal salmonellae are discussed separately. (See  <a class="medical medical_review" href="/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection"</a>.)</p><p>Acute diarrhea is also often approached syndromically, without knowledge of the causative pathogen. This approach differs somewhat by age and setting and is discussed separately. (See  <a class="medical medical_review" href="/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings"</a> and  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings"</a> and  <a class="medical medical_review" href="/d/html/6456.html" rel="external">"Diagnostic approach to diarrhea in children in resource-abundant settings", section on 'Acute diarrhea (typical duration &lt;5 days)'</a> and  <a class="medical medical_review" href="/d/html/2689.html" rel="external">"Causes of acute infectious diarrhea and other foodborne illnesses in resource-abundant settings", section on 'Overview of causes'</a>.)</p><p class="headingAnchor" id="H1058721092"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Nontyphoidal salmonellae are a major cause of diarrhea worldwide. In the United States, nontyphoidal salmonellosis is a leading cause of foodborne disease [<a href="#rid1">1</a>]. Frequently isolated serotypes include <em>S. </em>Enteritidis, <em>S. </em>Newport, and <em>S. </em>Typhimurium  (<a class="graphic graphic_table graphicRef81462" href="/d/graphic/81462.html" rel="external">table 1</a>).</p><p><em>Salmonella</em> is most commonly associated with the ingestion of poultry, eggs, and milk products. Other associations include fresh produce, meats, and other foods, as well as contact with pets (including reptiles) and other animals [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/d/html/2683.html" rel="external">"Nontyphoidal Salmonella: Microbiology and epidemiology", section on 'Epidemiology'</a>.)</p><p>Risk factors for severe infection are discussed separately  (<a class="graphic graphic_table graphicRef51300" href="/d/graphic/51300.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/2683.html" rel="external">"Nontyphoidal Salmonella: Microbiology and epidemiology", section on 'Risk for severe disease'</a>.)</p><p class="headingAnchor" id="H3503759056"><span class="h1">GASTROINTESTINAL INFECTION</span></p><p class="headingAnchor" id="H2732253064"><span class="h2">Clinical manifestations</span></p><p class="headingAnchor" id="H2717158"><span class="h3">Incubation period</span><span class="headingEndMark"> — </span>Symptoms <em>of Salmonella</em> gastroenteritis typically occur within 8 to 72 hours following exposure (which usually consists of ingestion of contaminated food or water). Longer incubation periods have been reported in some outbreaks; this may be attributable to a lower bacterial dose [<a href="#rid3">3,4</a>].</p><p class="headingAnchor" id="H1058721067"><span class="h3">General features</span><span class="headingEndMark"> — </span>Gastroenteritis due to salmonellae is clinically indistinguishable from gastroenteritis caused by many other pathogens. The cardinal features include diarrhea, nausea, vomiting, fever, and abdominal cramping. A higher ingested dose of bacteria correlates with the severity of diarrhea, the duration of illness, and weight loss [<a href="#rid5">5</a>]. The diarrhea is typically not grossly bloody, although bloody stools can be seen, particularly among children [<a href="#rid6">6,7</a>]. Other constitutional symptoms (fatigue, malaise, chills) and headache are also commonly described.</p><p>Enteric infection with nontyphoidal salmonellae may be clinically mild or even asymptomatic. (See <a class="local">'Asymptomatic carriage'</a> below.)</p><p class="headingAnchor" id="H2716953"><span class="h3">Clinical course</span><span class="headingEndMark"> — </span>Nontyphoidal<em> Salmonella</em> gastroenteritis is usually self-limited. Fever generally resolves within 48 to 72 hours, and diarrhea resolves within 4 to 10 days [<a href="#rid7">7,8</a>].</p><p>Mortality rates of 0.5 to 1 percent have been reported in outbreaks of <em>S. </em>Enteritidis, but these are most likely overestimates since milder cases tend to be unrecognized [<a href="#rid9">9,10</a>].</p><p>Following acute infection, the median duration of intermittent stool shedding is approximately five weeks. (See <a class="local">'Asymptomatic carriage'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h3">Complications/invasive disease</span><span class="headingEndMark"> — </span>Fewer than 5 percent of individuals with documented <em>Salmonella</em> gastroenteritis develop bacteremia [<a href="#rid7">7,11</a>]. Bacteremia can lead to a variety of extraintestinal manifestations such as endocarditis, mycotic aneurysm, visceral abscesses, and osteomyelitis [<a href="#rid12">12</a>]. <em>Salmonella</em> meningitis is a rare complication that typically occurs in neonates and children ≤1 year of age [<a href="#rid13">13,14</a>]. In addition, outbreaks of salmonellosis in neonatal intensive care units and maternity wards have been described [<a href="#rid15">15,16</a>].</p><p>Comorbidities that increase the risk of complications are discussed below. (See <a class="local">'Follow-up'</a> below.)</p><p>Some serotypes appear to be more invasive than others; however, clinical manifestations attributable to a particular serotype may be variable, geographically and temporally. Examples of serotypes associated with increased risk for bacteremia include <em>S.</em> <em>choleraesuis</em> [<a href="#rid17">17,18</a>], <em>S. heidelberg</em> [<a href="#rid19">19,20</a>], and antibiotic-resistant strains of <em>S. typhimurium</em> [<a href="#rid11">11,21</a>].</p><p>Issues related to invasive salmonellosis are discussed further separately. (See  <a class="medical medical_review" href="/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection"</a>.)</p><p class="headingAnchor" id="H1058721080"><span class="h2">Diagnosis and evaluation</span></p><p class="headingAnchor" id="H517660110"><span class="h3">Clinical approach</span><span class="headingEndMark"> — </span>Nontyphoidal <em>Salmonella</em> gastroenteritis is generally suspected as part of the differential diagnosis of acute diarrhea, particularly when accompanied by fever or in the setting of a community outbreak. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stool culture</strong> – Definitive diagnosis of <em>Salmonella</em> gastroenteritis requires isolation of the pathogen from stool culture; however, stool cultures are not always warranted. Indications for stool cultures in a patient presenting with acute diarrhea include severe illness, immunocompromising conditions, and comorbidities that increase the risk for complications; these indications are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/2683.html" rel="external">"Nontyphoidal Salmonella: Microbiology and epidemiology", section on 'Risk for severe disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood culture</strong> – Among patients with known or suspected <em>Salmonella </em>gastroenteritis, blood cultures should be obtained in patients ill enough to require hospitalization, patients with endovascular grafts or known atherosclerosis, and patients &lt;12 months or &gt;50 years of age. </p><p></p><p class="headingAnchor" id="H3869766085"><span class="h3">Laboratory tools</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Culture</strong> – Laboratory isolation of salmonellae from stool usually requires a minimum of 48 hours; 72 hours is needed if overnight enrichment broth incubation is used in addition to primary plating of stool samples.</p><p></p><p class="bulletIndent1">Salmonellae are gram-negative, facultatively anaerobic Enterobacteriaceae, which are differentiated from the normal gram-negative flora of the intestinal tract, in part, by the color of the colonies on indicator plates [<a href="#rid22">22</a>].</p><p></p><p class="bulletIndent1">The sensitivity and specificity of single or multiple stool cultures for diagnosis of salmonellosis are unknown.</p><p></p><p class="bulletIndent1">Enrichment broths (tetrathionate or selenite) are used to facilitate the identification of <em>Salmonella</em> when low numbers of organisms are present. Overnight incubation in these broths inhibits the growth of <em>Escherichia coli</em> but not <em>Salmonella</em>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Molecular tools</strong> – Highly sensitive multiplex nucleic acid amplification tests are commercially available for detection of <em>Salmonella</em> and other enteric pathogens in stool samples; their clinical utility remains uncertain, especially since these tests do not provide antimicrobial resistance results [<a href="#rid23">23-25</a>]. (See  <a class="medical medical_review" href="/d/html/2683.html" rel="external">"Nontyphoidal Salmonella: Microbiology and epidemiology", section on 'Microbiology'</a>.)</p><p></p><p class="headingAnchor" id="H2717239"><span class="h2">Differential diagnosis</span><span class="headingEndMark"> — </span>Most cases of acute diarrhea are due to infection. The other major causes of acute infectious diarrhea include viruses (eg, norovirus, rotavirus, adenoviruses, astrovirus), other bacteria (eg, <em>Campylobacter</em>, <em>Shigella</em>, Shiga-toxin producing <em>E. coli</em>, <em>Vibrio</em>, <em>Clostridioides</em> <em>difficile</em>), and protozoa (eg, cryptosporidium, giardia, cyclospora, entamoeba). </p><p>It is difficult to distinguish infections caused by the different pathogens on the basis of clinical features alone, but identifying a pathogen is not always warranted for clinical management. The differential diagnosis and approach to acute diarrhea are discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings"</a> and  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings"</a> and  <a class="medical medical_review" href="/d/html/6456.html" rel="external">"Diagnostic approach to diarrhea in children in resource-abundant settings", section on 'Acute diarrhea (typical duration &lt;5 days)'</a> and  <a class="medical medical_review" href="/d/html/2689.html" rel="external">"Causes of acute infectious diarrhea and other foodborne illnesses in resource-abundant settings", section on 'Overview of causes'</a>.)</p><p class="headingAnchor" id="H6"><span class="h2">Management</span><span class="headingEndMark"> — </span>The cornerstone of treatment of individuals with <em>Salmonella</em> gastroenteritis is the replacement of fluids and electrolytes. The illness is usually self-limited, and most <em>Salmonella</em> infections are not associated with complications.</p><p>Antimicrobial therapy may be warranted for those with severe disease or risk factors for invasive disease.</p><p class="headingAnchor" id="H52930749"><span class="h3">Supportive care</span><span class="headingEndMark"> — </span>The most critical therapy in diarrheal illness is hydration, preferably by the oral route with solutions that contain water, salt, and sugar. This is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings", section on 'Fluid repletion'</a> and  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings", section on 'Rehydration'</a> and  <a class="medical medical_review" href="/d/html/6103.html" rel="external">"Treatment of hypovolemia (dehydration) in children in resource-abundant settings"</a>.) </p><p class="headingAnchor" id="H1058721973"><span class="h3">Antimicrobial therapy</span><span class="headingEndMark"> — </span>Decisions about antimicrobial therapy are generally made empirically at the time of clinical presentation. The approach to empiric antimicrobial therapy for infectious diarrhea is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/2717.html" rel="external">"Approach to the adult with acute diarrhea in resource-abundant settings"</a> and  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings"</a> and  <a class="medical medical_review" href="/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings"</a>.)</p><p>The approach to antimicrobial therapy for patients with documented <em>Salmonella</em> gastroenteritis is discussed below. </p><p>Management of extraintestinal <em>Salmonella</em> infection is discussed separately. (See  <a class="medical medical_review" href="/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection", section on 'Management'</a>.)</p><p class="headingAnchor" id="H52930797"><span class="h4">Indications</span><span class="headingEndMark"> — </span>Antibiotic treatment for <em>Salmonella</em> gastroenteritis is warranted for the treatment of patients with severe illness and for the treatment of patients at high risk for invasive disease. In these groups, the potential for improvement of severe illness and prevention of complications seems to outweigh the risks of antibiotic treatment, although this has not been definitively demonstrated in large, randomized trials. </p><p class="headingAnchor" id="H4000362461"><span class="h5">Low risk for invasive disease</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mild to moderate symptoms</strong> – For immunocompetent individuals between 12 months and 50 years of age with <em>Salmonella</em> gastroenteritis and mild to moderate symptoms, we generally do not administer antibiotic therapy since the illness is typically self-limited. Risks of treatment include the adverse effects of the antimicrobial agent (including overall antimicrobial resistance pressure) and extending the duration of asymptomatic <em>Salmonella</em> carriage.</p><p></p><p class="bulletIndent1">This approach is supported by a meta-analysis of 12 trials that included 767 otherwise healthy individuals with nontyphoidal <em>Salmonella</em> gastroenteritis; there was no significant benefit from antimicrobial therapy on the duration of illness, diarrhea, or fever [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1">Short-term antibiotic use may be associated with a longer duration of stool shedding [<a href="#rid27">27,28</a>]. In a 1992 study including more than 500 patients with salmonellosis, treatment with <a class="drug drug_general" data-topicid="9710" href="/d/drug information/9710.html" rel="external">norfloxacin</a> was associated with a longer time to stool culture clearance compared with placebo (median 50 versus 23 days) [<a href="#rid27">27</a>]. This may be due to a deleterious effect of antibiotics on the gut microbiome, which contributes to colonization resistance and pathogen eradication.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe illness</strong> — Severe illness due to <em>Salmonella</em> gastroenteritis is characterized by:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Severe diarrhea (more than 9 or 10 stools per day)</p><p class="bulletIndent2"><span class="glyph">•</span>High or persistent fever</p><p class="bulletIndent2"><span class="glyph">•</span>Need for hospitalization</p><p></p><p class="bulletIndent1">For immunocompetent individuals with severe illness, antimicrobial treatment is appropriate; the decision to treat should be individualized. </p><p></p><p class="bulletIndent1">The presence of bloody diarrhea does <strong>not</strong> necessarily indicate the need for antimicrobial treatment. Many patients with salmonellosis have occult blood detectable in stool samples, while overtly bloody stools are more likely to be due to <em>Shigella</em> or enterohemorrhagic <em>E. coli. </em>Antibiotic treatment of diarrhea caused by enterohemorrhagic <em>E. coli</em> has been associated with Shiga-toxin mediated hemolytic uremic syndrome. (See  <a class="medical medical_review" href="/d/html/2714.html" rel="external">"Shiga toxin-producing Escherichia coli: Clinical manifestations, diagnosis, and treatment", section on 'Antibiotics'</a>.)</p><p></p><p class="bulletIndent1">Use of antibiotics in patients with severe illness is supported by trials suggesting that empiric antimicrobial treatment of patients with severe community-acquired diarrhea improves symptoms and speeds clinical recovery by one to two days [<a href="#rid27">27,29-31</a>]. Studies included in the meta-analysis discussed above that showed minimal clinical benefit of antimicrobial treatment of nontyphoidal <em>Salmonella</em> gastroenteritis generally excluded patients with severe disease [<a href="#rid26">26</a>]. </p><p></p><p class="headingAnchor" id="H2710139622"><span class="h5">High risk for invasive disease</span><span class="headingEndMark"> — </span>Antibiotic therapy is warranted for certain patients at high risk for complications <em>of Salmonella</em> intestinal infection (such as bacteremia and metastatic foci of infection), regardless of the severity of disease. Such patients include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Infants &lt;12 months</strong> – Neonates with gastroenteritis, particularly those born prematurely and/or to mothers with gastroenteritis, are at risk though they may not appear toxic or acutely ill [<a href="#rid20">20,32,33</a>]. However, <em>Salmonella</em> meningitis is a potential complication that occurs primarily in infants and has a high case fatality rate and a significant rate of neurologic complications [<a href="#rid34">34</a>]. </p><p></p><p class="bulletIndent1">Infants younger than three months of age should receive antimicrobial therapy for symptomatic salmonellosis [<a href="#rid35">35-37</a>]. Some experts treat children younger than one to two years of age unless the child is afebrile and clinically improving at the time the culture results become available [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adults &gt;50 years</strong> – Adults &gt;50 years of age, particularly those with known atherosclerotic disease, are at higher risk of endovascular infection and aortitis if bacteremia develops. Older studies showed that approximately 10 percent of adults &gt;50 years of age with nontyphoidal <em>Salmonella </em>bacteremia were found to have infective arteritis [<a href="#rid38">38,39</a>]. Those with endovascular or osseous prostheses may also reasonably be considered to have a similar risk of metastatic infection and warrant antibiotic therapy even if not severely ill with gastroenteritis.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with poorly controlled human immunodeficiency virus (HIV) infection</strong> – In two studies (one from Malawi and the other from Taiwan), 31 and 43 percent of antiretroviral-naïve adults with HIV infection developed recurrent <em>Salmonella</em> bacteremia [<a href="#rid40">40,41</a>]. The risk of severe and recurrent nontyphoidal salmonellosis has decreased as more HIV patients receive antiretroviral therapy [<a href="#rid42">42</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with immunosuppression</strong> in the following categories:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Organ transplant recipients</p><p class="bulletIndent2"><span class="glyph">•</span>Patients receiving corticosteroids or other immunosuppressive agents</p><p class="bulletIndent2"><span class="glyph">•</span>Patients with cancer or lymphoproliferative disease with current or recent chemotherapy</p><p class="bulletIndent2"><span class="glyph">•</span>Patients with sickle cell disease or other hemoglobinopathies</p><p class="bulletIndent2"><span class="glyph">•</span>Patients with disorders of the reticuloendothelial system, including cirrhosis</p><p></p><p class="bulletIndent1">Immune compromise is an important risk factor for <em>Salmonella</em> bacteremia and extraintestinal infection; such patients should be evaluated carefully for these complications [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patients with endovascular abnormalities or implanted prosthetic materials</strong> – This primarily includes patients with atherosclerotic disease, prosthetic heart valves, or prosthetic joints.</p><p></p><p class="bulletIndent1">The association between these host factors and severe disease is discussed further separately. (See  <a class="medical medical_review" href="/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection", section on 'Host risk factors'</a> and  <a class="medical medical_review" href="/d/html/2683.html" rel="external">"Nontyphoidal Salmonella: Microbiology and epidemiology", section on 'Risk for severe disease'</a>.)</p><p></p><p class="headingAnchor" id="H1058721980"><span class="h4">Empiric antibiotic selection</span><span class="headingEndMark"> — </span>Given the increasing prevalence of antimicrobial resistance, local antibiotic resistance patterns must be taken into account when choosing empiric therapy. Antibiotic therapy should be tailored to susceptibility data once available. (See  <a class="medical medical_review" href="/d/html/2683.html" rel="external">"Nontyphoidal Salmonella: Microbiology and epidemiology", section on 'Antimicrobial resistance'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonpregnant adults and adolescents</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Oral therapy</strong> – Fluoroquinolones (eg, <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> 500 mg orally twice daily or <a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">levofloxacin</a> 500 mg orally once daily) are preferred (in the absence of contraindications) because of their activity against most common gram-negative enteric pathogens, their high tissue and intracellular concentrations, and their favorable side effect profile. </p><p></p><p class="bulletIndent2">Alternative oral antibiotic agents include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">Trimethoprim-sulfamethoxazole</a> (160 mg/800 mg orally twice daily)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9216" href="/d/drug information/9216.html" rel="external">Cefixime</a> (400 mg orally once or twice daily)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">Azithromycin</a> (1 gram, followed by 500 mg daily for five to seven days). It should be noted that antimicrobial resistance testing of Salmonellae for azithromycin susceptibility is not standardized and may not be performed by many laboratories.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">Amoxicillin</a> (high dose: 1 gram orally three times daily) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Parenteral therapy</strong> – For patients with severe disease who cannot tolerate oral therapy, an intravenous fluoroquinolone or a third-generation cephalosporin (eg, <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> 1 to 2 g intravenously once daily or <a class="drug drug_general" data-topicid="9221" href="/d/drug information/9221.html" rel="external">cefotaxime</a> 2 g intravenously every eight hours) may be used.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Children</strong>  </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Oral therapy</strong> – For children who do not appear ill or have evidence of disseminated infection, oral <a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">azithromycin</a> (10 mg/kg on day 1 [maximum 500 mg], followed by 5 mg/kg [maximum 250 mg] daily for four additional days) may be given, pending blood culture results. </p><p></p><p class="bulletIndent2">Alternative agents include fluoroquinolone (<a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> or <a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">levofloxacin</a>), <a class="drug drug_general" data-topicid="8737" href="/d/drug information/8737.html" rel="external">ampicillin</a>, or <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a>, guided by susceptibility data. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Parenteral therapy</strong> – For children with known or suspected serious nontyphoidal <em>Salmonella</em> infection, <a class="drug drug_general" data-topicid="9229" href="/d/drug information/9229.html" rel="external">ceftriaxone</a> (50 mg/kg intravenous [IV] or intramuscular [IM]; maximum 1 gram) should be given [<a href="#rid35">35</a>]. </p><p></p><p class="headingAnchor" id="H52930790"><span class="h4">Duration</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunocompetent patients</strong> − For immunocompetent individuals with severe <em>Salmonella</em> gastroenteritis (in the absence of bacteremia), three to seven days of treatment is generally appropriate. This has been the range of durations evaluated in most studies of empiric treatment of severe community-acquired diarrhea [<a href="#rid27">27,29-31</a>]. </p><p></p><p class="bulletIndent1">For patients who are treated because of age or underlying vascular disease or the presence of implanted prosthetic devices (in the absence of severe gastrointestinal symptoms), the optimal duration is uncertain. Most experts would recommend 3 to 14 days of treatment depending upon the specific clinical situation, suspicion for bacteremia, laboratory findings, and microbiologic data. </p><p></p><p class="bulletIndent1">Overall, it is prudent to limit antibiotic exposure in immunocompetent patients since antibiotic treatment has potential to paradoxically prolong carriage (see <a class="local">'Asymptomatic carriage'</a> below). In addition, antibiotic treatment confers the risks of adverse drug reactions and antibiotic resistance. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunocompromised patients</strong> − We treat immunocompromised patients with salmonellosis for at least 14 days (weeks to months in some cases), with the goal of preventing persistent or relapsing infection. Decisions on the precise duration of treatment should be individualized in consultation with an expert in infectious diseases. In addition, such patients should be evaluated carefully for bacteremia or extraintestinal infection. </p><p></p><p class="bulletIndent1">In a retrospective study of patients with cancer (primarily hematologic malignancies) and nontyphoidal salmonellosis, relapse occurred only among patients treated for ≤10 days [<a href="#rid44">44</a>]. (See  <a class="medical medical_review" href="/d/html/3126.html" rel="external">"Nontyphoidal <i>Salmonella </i>bacteremia and extraintestinal infection"</a>.) </p><p></p><p class="bulletIndent1">For patients with HIV infection and CD4 cell count &lt;200 cells/microL, treatment consists of two to six weeks of antibiotics [<a href="#rid45">45</a>]. </p><p></p><p class="headingAnchor" id="H52933353"><span class="h4">Follow-up</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of stool cultures </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For immunocompetent patients whose symptoms have resolved, there is no role for routine follow-up stool culture to evaluate for clearance of <em>Salmonella</em>. Continued short-term shedding of <em>Salmonella</em> following intestinal infection is common, may persist for weeks, and may be episodic. </p><p></p><p class="bulletIndent2">Issues related to food handlers, healthcare workers, and childcare workers are discussed below. (See <a class="local">'Food handlers, healthcare workers, and childcare workers'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Follow-up stool cultures may be informative in patients with persistent or relapsing symptoms [<a href="#rid28">28</a>] or in medically complicated or immunosuppressed patients at high risk of either recurrent/relapsed infection or bacteremia. </p><p></p><p class="bulletIndent2">Such patients include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with cancer who are receiving chemotherapy, especially if mucositis and/or neutropenia is anticipated</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Organ transplant recipients</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with advanced or poorly controlled HIV infection</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with prior history of relapsing gastrointestinal or bacteremic nontyphoidal salmonellosis </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Patients with prosthetic heart valves or others in whom complications of bacteremia may have serious consequences</p><p></p><p class="bulletIndent2">It is reasonable to collect stool samples upon recurrence of gastrointestinal symptoms or in asymptomatic immunosuppressed patients. Samples should be obtained at least one week after discontinuation of antibiotics and at least one month after illness onset. Typically three stool samples are collected at least 24 hours apart since stool shedding may be episodic; a single negative stool culture may seem reassuring but does not ensure that the individual is no longer shedding [<a href="#rid46">46</a>].  </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment approach for patients with persistent or relapsing symptomatic infection</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotic therapy</strong> – For patients who warrant follow-up cultures (outlined in the preceding section above), decisions regarding further antibiotic treatment should be individualized in consultation with infectious disease expertise. Clinical considerations include patient comorbidities, current and anticipated immune status, the likelihood of serious complications related to <em>Salmonella</em> carriage, and a risk/benefit analysis of prolonged antimicrobial therapy (including adverse effects on the gut microbiome). Antibiotic selection should be guided by susceptibility data; the duration is generally four to six weeks.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Novel treatment approaches</strong> – Administration of antibiotics followed by fecal transplant for eradication of antibiotic-resistant nontyphoidal <em>Salmonella</em> in patients with relapsing gastroenteritis has been described; this highlights the importance of a normal gastrointestinal flora in clearing salmonellosis, as well as the limitations of antibiotic therapy [<a href="#rid47">47</a>]. Another report described clearance of chronic gastrointestinal infection after administration of a symbiotic (probiotic microbes and prebiotic fructo-oligosaccharide) [<a href="#rid48">48</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Children who attend a childcare center </strong>– For children who attend a childcare center, the American Academy of Pediatrics Red Book recommends allowing children to return to care if stools are contained in the diaper, or, for toilet-trained children, when they are continent [<a href="#rid35">35</a>]. In addition, stool frequency should be no more than two stools above normal frequency for the period the child is in the program.</p><p></p><p class="headingAnchor" id="H3207653508"><span class="h3">Pregnant patients and their neonates</span><span class="headingEndMark"> — </span>Pregnant patients acquire nontyphoidal <em>Salmonella</em> infection at rates similar to the general population [<a href="#rid49">49,50</a>]. Pregnancy does not necessarily increase the severity of illness; however, there are case reports of pregnant patients with severe nontyphoidal <em>Salmonella</em> infection, and fetal loss in the setting of disseminated infection is possible in any trimester [<a href="#rid51">51-53</a>]. Transplacental transmission is possible and can precipitate preterm delivery and neonatal complications [<a href="#rid54">54</a>]. Pregnant patients with fever and gastroenteritis symptoms should be evaluated for salmonellosis as well as other enteric bacterial infections (including <em>Listeria</em> and <em>Campylobacter</em>).</p><p>Indications for treatment of pregnant patients with salmonellosis are the same as for nonpregnant patients, outlined above. (See <a class="local">'Indications'</a> above.)</p><p>Patients with peripartum infection may shed organisms during childbirth, with risk for neonatal transmission of infection [<a href="#rid55">55</a>]. Given the risk for invasive disease among neonates with salmonellosis, consideration should be given to screening cultures for both mother and infant. Timing of the mother's infection relative to delivery is an important consideration; consultation with infectious disease experts is advised.</p><p class="headingAnchor" id="H1448352339"><span class="h2">Preventing transmission</span><span class="headingEndMark"> — </span>Fecal-oral transmission is often related to poor handwashing practices; hand hygiene and careful attention to general infection control practices are the most important aspects of preventing transmission of <em>Salmonella</em> [<a href="#rid56">56,57</a>]. </p><p>Individuals at increased risk for transmission of salmonellosis to others include food handlers, healthcare workers, and childcare workers. (See <a class="local">'Food handlers, healthcare workers, and childcare workers'</a> below.)</p><p class="headingAnchor" id="H1058722184"><span class="h1">ASYMPTOMATIC CARRIAGE</span><span class="headingEndMark"> — </span>The approach for individuals with asymptomatic carriage of nontyphoidal salmonellosis is discussed below; it differs from the approach for individuals with chronic carriage of <em>S</em>. Typhi, which is discussed separately. (See  <a class="medical medical_review" href="/d/html/2712.html" rel="external">"Enteric (typhoid and paratyphoid) fever: Treatment and prevention", section on 'Follow-up'</a>.)</p><p class="headingAnchor" id="H2321384093"><span class="h2">General principles</span><span class="headingEndMark"> — </span>Following acute infection, the median duration of intermittent stool shedding is approximately five weeks [<a href="#rid46">46</a>]. </p><p>Chronic carriage is defined as the shedding of a Salmonella species for more than one year, as documented by an initial positive culture of a stool sample obtained at least one month after resolution of the acute illness, followed by repeat positive cultures. Chronic carriage occurs in &lt;1 percent of patients following nontyphoidal <em>Salmonella</em> infection (0.2 to 0.6 percent in one study) [<a href="#rid58">58</a>]. Among patients &lt;5 years of age, chronic carriage occurs in approximately 2.5 percent of patients. Carriage may be more common in patients with biliary tract abnormalities, especially gallstones. Chronic carriage may be identified incidentally (as part of public health follow-up), or when episodic or recurrent gastrointestinal symptoms prompt additional testing.</p><p class="headingAnchor" id="H1788930126"><span class="h2">Food handlers, healthcare workers, and childcare workers</span><span class="headingEndMark"> — </span>Food handlers, healthcare workers, and childcare workers may unknowingly shed <em>Salmonella</em> transiently. Such individuals may be asymptomatic or have mild, undiagnosed gastrointestinal illness with the potential to transmit infection to others at risk for severe or invasive disease. </p><p>In a report of foodborne illness in the United States between 2017 and 2019, <em>Salmonella</em> was the second most common pathogen associated with foodborne outbreaks related to retail food establishments [<a href="#rid59">59</a>]; however, <em>Salmonella</em> organisms contaminate many components of the food chain. (See  <a class="medical medical_review" href="/d/html/2683.html" rel="external">"Nontyphoidal Salmonella: Microbiology and epidemiology", section on 'Foodborne infection'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention and infection control</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Importance of handwashing</strong> – Hand hygiene and general infection control practices are the most important aspects of preventing transmission of <em>Salmonella</em>. Nosocomial fecal-oral transmission is often related to poor handwashing practices [<a href="#rid56">56,57</a>]. The efficacy of proper handwashing was illustrated in one report of a foodborne outbreak of salmonellosis among nurses in which no transmission to patients occurred [<a href="#rid60">60</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>No efficacy for screening asymptomatic workers</strong> – There is no evidence that screening for asymptomatic carriage is effective in reducing transmission. Furthermore, transmission from asymptomatic food handlers has only rarely been documented [<a href="#rid61">61,62</a>]. One outbreak occurred in Jordan despite routine surveillance of kitchen employees for <em>Salmonella</em> carriage [<a href="#rid62">62</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Quarantine</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Symptomatic workers should remain home</strong> – It is reasonable and customary for symptomatic food handlers, healthcare workers, and childcare workers to remain home from work while gastroenteritis symptoms persist; organism excretion occurs more frequently and at higher levels during symptomatic illness [<a href="#rid63">63</a>]. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluation prior to returning to work</strong> – In the United States, some states require one or more negative stool cultures before such employees can return to work (see <a class="local">'Follow-up'</a> above). As national policy is not mandated, judgment should be guided by local public health requirements and individual circumstances. In the setting of a salmonellosis outbreak linked to a specific facility serving the public, health departments may have stricter or legally mandated requirements. </p><p></p><p class="bulletIndent2">Obtaining stool cultures may be warranted for individuals whose work includes direct handling of food consumed without further cooking, or direct contact with immunosuppressed patients. However, it does not seem reasonable to implement this approach routinely for employees with lower risk occupations. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role of antibiotics for asymptomatic carriage</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>No role for routine treatment</strong> – We do not routinely treat chronic asymptomatic nontyphoidal salmonella carriage in food handlers and healthcare workers. Antibiotic treatment of asymptomatic carriage is not highly effective for eradication; in contrast, it may prolong the duration of carriage as well as promote antimicrobial resistance. </p><p></p><p class="bulletIndent2">In a Thai study including more than 260 food handlers with asymptomatic carriage who were randomly assigned to treatment with <a class="drug drug_general" data-topicid="9710" href="/d/drug information/9710.html" rel="external">norfloxacin</a>, <a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">azithromycin</a>, or placebo, eradications were comparable [<a href="#rid64">64</a>]. In addition, antibiotic use was associated with selection of drug-resistant <em>Salmonella</em>. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment in select cases</strong> – For situations in which treatment is determined to be advisable by clinicians and public health authorities (examples include healthcare workers caring for immunocompromised hosts, including feeding such patients, or food handlers linked to an outbreak), antibiotic eradication may be reasonably attempted. Early, direct communication with public health authorities is advised.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Antibiotic selection </strong>– For patients with a fluoroquinolone-susceptible isolate, treatment with <a class="drug drug_general" data-topicid="9267" href="/d/drug information/9267.html" rel="external">ciprofloxacin</a> (500 mg orally twice daily) or <a class="drug drug_general" data-topicid="9554" href="/d/drug information/9554.html" rel="external">levofloxacin</a> (500 mg orally once daily) for four weeks is reasonable.</p><p></p><p class="bulletIndent3">For patients with a fluoroquinolone-nonsusceptible isolate, treatment should be guided by susceptibility data; possible regimens include high-dose <a class="drug drug_general" data-topicid="8673" href="/d/drug information/8673.html" rel="external">amoxicillin</a> (75 to 100 mg/kg per day) for six weeks or <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> (160 mg/800 mg orally twice daily) for three months.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Follow up</strong> – Three stool cultures obtained over a week, beginning at least a week after stopping antibiotics, would provide reasonable documentation of eradication.</p><p></p><p class="headingAnchor" id="H3590481365"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109942.html" rel="external">"Society guideline links: Acute diarrhea in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/110029.html" rel="external">"Society guideline links: Acute diarrhea in children"</a>.)</p><p class="headingAnchor" id="H14914420"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/83760.html" rel="external">"Patient education: Salmonella infection (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Symptoms of <em>Salmonella</em> gastroenteritis typically occur within 8 to 72 hours following exposure. The cardinal features include diarrhea, nausea, vomiting, fever, and abdominal cramping; these are usually self-limited. Fever generally resolves within 48 to 72 hours, and diarrhea within 4 to 10 days. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis and evaluation</strong> – Nontyphoidal <em>Salmonella</em> gastroenteritis is generally suspected as part of the differential diagnosis of acute diarrhea, particularly when accompanied by fever or in the setting of a community outbreak. Gastroenteritis due to salmonellae is clinically indistinguishable from gastroenteritis caused by other pathogens, and definitive diagnosis requires isolation of <em>Salmonella</em> from stool culture. (See <a class="local">'Diagnosis and evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Supportive care</strong> – The cornerstone of therapy for symptomatic <em>Salmonella</em> gastroenteritis is hydration. (See <a class="local">'Supportive care'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role for antimicrobial therapy</strong> – The role of antibiotics depends upon the clinical setting.</p><p></p><p class="bulletIndent2">For immunocompetent patients 12 months to 50 years old with mild to moderate illness due to <em>Salmonella</em> gastroenteritis, we suggest <strong>not</strong> routinely treating with antibiotics (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). In such patients, antimicrobial therapy does not shorten the duration of illness and can increase the risk of extended asymptomatic <em>Salmonella </em>carriage. (See <a class="local">'Low risk for invasive disease'</a> above.)</p><p></p><p class="bulletIndent2">For patients with severe illness (severe diarrhea, high or persistent fever, need for hospitalization) and for patients at high risk for invasive disease, the potential for antibiotics to improve disease or prevent complications appears to outweigh the risks of antibiotic use. Patients at high risk for invasive disease include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Infants &lt;12 months</p><p class="bulletIndent3"><span class="glyph">-</span>Adults &gt;50 years, especially those with known vascular disease</p><p class="bulletIndent3"><span class="glyph">-</span>Patients with poorly controlled HIV infection</p><p class="bulletIndent3"><span class="glyph">-</span>Patients with immunosuppression</p><p class="bulletIndent3"><span class="glyph">-</span>Patients with atherosclerotic disease, prosthetic heart valves, or prosthetic joints.</p><p></p><p class="bulletIndent2">For these individuals, we suggest treating <em>Salmonella</em> gastroenteritis with antibiotics (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'High risk for invasive disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotic selection</strong> – For adults and adolescents who warrant antibiotic treatment for <em>Salmonella</em> gastroenteritis, we favor fluoroquinolones. For children who warrant treatment, <a class="drug drug_general" data-topicid="9041" href="/d/drug information/9041.html" rel="external">azithromycin</a> may be used. Other appropriate antibiotic choices include <a class="drug drug_general" data-topicid="9785" href="/d/drug information/9785.html" rel="external">trimethoprim-sulfamethoxazole</a> or <a class="drug drug_general" data-topicid="9216" href="/d/drug information/9216.html" rel="external">cefixime</a>. (See <a class="local">'Empiric antibiotic selection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Antibiotic duration</strong> (see <a class="local">'Duration'</a> above) </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For immunocompetent individuals with severe <em>Salmonella</em> gastroenteritis (in the absence of bacteremia), three to seven days of treatment is generally appropriate. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For immunocompetent patients who are treated because of age or underlying vascular disease, or the presence of implanted prosthetic devices (in the absence of severe gastrointestinal symptoms), 3 to 14 days of treatment is reasonable, depending upon the specific clinical situation, laboratory findings, and microbiologic data. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>For immunocompromised patients, we treat for at least 14 days (weeks to months in some cases), with the goal of preventing persistent or relapsing infection. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Follow-up</strong> (see <a class="local">'Follow-up'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role of stool cultures</strong> – For immunocompetent patients whose symptoms have resolved, there is no role for routine follow-up stool culture to evaluate for clearance of <em>Salmonella</em>. </p><p></p><p class="bulletIndent2">Follow-up stool cultures may be informative in patients with persistent or relapsing symptoms or in medically complicated or immunosuppressed patients at high risk of either recurrent/relapsed infection or bacteremia. It is reasonable to collect stool samples upon recurrence of gastrointestinal symptoms or in asymptomatic immunosuppressed patients. </p><p></p><p class="bulletIndent2">Samples should be obtained at least one week after discontinuation of antibiotics and at least one month after illness onset. Typically, three stool samples are collected at least 24 hours apart since stool shedding may be episodic.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treatment approach</strong> – For patients who warrant follow-up cultures, decisions regarding further antibiotic treatment should be individualized in consultation with infectious disease expertise. Clinical considerations include patient comorbidities, current and anticipated immune status, the likelihood of serious complications related to <em>Salmonella</em> carriage, and a risk/benefit analysis of prolonged antimicrobial therapy (including adverse effects on the gut microbiome). Antibiotic selection should be guided by susceptibility data; the duration is generally four to six weeks.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Food handlers, healthcare workers, and childcare workers</strong> – Food handlers, healthcare workers, and childcare workers may unknowingly serve as transient <em>Salmonella </em>excreters. Such individuals may be asymptomatic or have mild, undiagnosed gastrointestinal illness, with the potential to transmit the infection to others at risk for severe or invasive disease. (See <a class="local">'Food handlers, healthcare workers, and childcare workers'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Quarantine</strong> – Food handlers, healthcare workers, and childcare workers with symptomatic gastroenteritis should remain home from work. In the United States, some states require one or more negative stool cultures (more than 48 hours after discontinuation of antibiotics, if given) before such employees can return to work. As national policy is not mandated, judgment should be guided by local public health requirements and individual circumstances. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Role for antibiotic therapy</strong> – For situations in which treatment is determined to be advisable by clinicians and public health authorities (examples include healthcare workers caring for immunocompromised hosts, including feeding such patients, or food handlers linked to an outbreak), antibiotic eradication may be reasonably attempted. Early, direct communication with public health authorities is advised.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Delahoy MJ, Shah HJ, Weller DL, et al. Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022. MMWR Morb Mortal Wkly Rep 2023; 72:701.</a></li><li><a class="nounderline abstract_t">Faulder KE, Simmonds K, Robinson JL. The Epidemiology of Childhood Salmonella Infections in Alberta, Canada. Foodborne Pathog Dis 2017; 14:364.</a></li><li><a class="nounderline abstract_t">Brooks JT, Matyas BT, Fontana J, et al. An outbreak of Salmonella serotype Typhimurium infections with an unusually long incubation period. Foodborne Pathog Dis 2012; 9:245.</a></li><li><a class="nounderline abstract_t">Abe K, Saito N, Kasuga F, Yamamoto S. Prolonged incubation period of salmonellosis associated with low bacterial doses. J Food Prot 2004; 67:2735.</a></li><li><a class="nounderline abstract_t">Mintz ED, Cartter ML, Hadler JL, et al. Dose-response effects in an outbreak of Salmonella enteritidis. Epidemiol Infect 1994; 112:13.</a></li><li><a class="nounderline abstract_t">Liu LJ, Yang YJ, Kuo PH, et al. Diagnostic value of bacterial stool cultures and viral antigen tests based on clinical manifestations of acute gastroenteritis in pediatric patients. Eur J Clin Microbiol Infect Dis 2005; 24:559.</a></li><li><a class="nounderline abstract_t">SAPHRA I, WINTER JW. Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center. N Engl J Med 1957; 256:1128.</a></li><li><a class="nounderline abstract_t">From the Centers for Disease Control. Outbreak of Salmonella enteritidis infection associated with consumption of raw shell eggs. JAMA 1992; 267:3263.</a></li><li><a class="nounderline abstract_t">Helms M, Simonsen J, Molbak K. Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium. J Infect Dis 2004; 190:1652.</a></li><li><a class="nounderline abstract_t">Patrick ME, Adcock PM, Gomez TM, et al. Salmonella enteritidis infections, United States, 1985-1999. Emerg Infect Dis 2004; 10:1.</a></li><li><a class="nounderline abstract_t">Krueger AL, Greene SA, Barzilay EJ, et al. Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in FoodNet sites, 2006-2008. Foodborne Pathog Dis 2014; 11:335.</a></li><li><a class="nounderline abstract_t">Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore) 1987; 66:349.</a></li><li><a class="nounderline abstract_t">Sirinavin S, Chiemchanya S, Vorachit M. Systemic nontyphoidal Salmonella infection in normal infants in Thailand. Pediatr Infect Dis J 2001; 20:581.</a></li><li><a class="nounderline abstract_t">Molyneux EM, Mankhambo LA, Phiri A, et al. The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006. Ann Trop Paediatr 2009; 29:13.</a></li><li><a class="nounderline abstract_t">Umasankar S, Mridha EU, Hannan MM, et al. An outbreak of Salmonella enteritidis in a maternity and neonatal intensive care unit. J Hosp Infect 1996; 34:117.</a></li><li><a class="nounderline abstract_t">Mahajan R, Mathur M, Kumar A, et al. Nosocomial outbreak of Salmonella typhimurium infection in a nursery intensive care unit (NICU) and paediatric ward. J Commun Dis 1995; 27:10.</a></li><li><a class="nounderline abstract_t">SAPHRA I, WASSERMANN M. Salmonella cholerae suis: a clinical and epidemiological evaluation of 329 infections identified between 1940 and 1954 in the New York Salmonella Center. Am J Med Sci 1954; 228:525.</a></li><li><a class="nounderline abstract_t">Wang JH, Liu YC, Yen MY, et al. Mycotic aneurysm due to non-typhi salmonella: report of 16 cases. Clin Infect Dis 1996; 23:743.</a></li><li><a class="nounderline abstract_t">Cherubin CE, Neu HC, Imperato PJ, et al. Septicemia with non-typhoid salmonella. Medicine (Baltimore) 1974; 53:365.</a></li><li><a class="nounderline abstract_t">Rice PA, Craven C, Wells JG. Salmonella heidelberg enteritis and bacteremia. An epidemic on two pediatric wards. Am J Med 1976; 60:509.</a></li><li><a class="nounderline abstract_t">Varma JK, Molbak K, Barrett TJ, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis 2005; 191:554.</a></li><li><a class="nounderline abstract_t">Gal-Mor O. Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae. Clin Microbiol Rev 2019; 32.</a></li><li><a class="nounderline abstract_t">Perry MD, Corden SA, Howe RA. Evaluation of the Luminex xTAG Gastrointestinal Pathogen Panel and the Savyon Diagnostics Gastrointestinal Infection Panel for the detection of enteric pathogens in clinical samples. J Med Microbiol 2014; 63:1419.</a></li><li><a class="nounderline abstract_t">Murphy CN, Fowler RC, Iwen PC, Fey PD. Evaluation of the BioFire FilmArray® GastrointestinalPanel in a Midwestern Academic Hospital. Eur J Clin Microbiol Infect Dis 2017; 36:747.</a></li><li><a class="nounderline abstract_t">O'Boyle H, Kirpalani A, Weiss L, et al. Management and Outcomes of Salmonella Gastroenteritis in the Era of Rapid Molecular Testing. Hosp Pediatr 2022; 12:1011.</a></li><li><a class="nounderline abstract_t">Onwuezobe IA, Oshun PO, Odigwe CC. Antimicrobials for treating symptomatic non-typhoidal Salmonella infection. Cochrane Database Syst Rev 2012; 11:CD001167.</a></li><li><a class="nounderline abstract_t">Wiström J, Jertborn M, Ekwall E, et al. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. Ann Intern Med 1992; 117:202.</a></li><li><a class="nounderline abstract_t">Marzel A, Desai PT, Goren A, et al. Persistent Infections by Nontyphoidal Salmonella in Humans: Epidemiology and Genetics. Clin Infect Dis 2016; 62:879.</a></li><li><a class="nounderline abstract_t">Mattila L, Peltola H, Siitonen A, et al. Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis 1993; 17:779.</a></li><li><a class="nounderline abstract_t">Dryden MS, Gabb RJ, Wright SK. Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin. Clin Infect Dis 1996; 22:1019.</a></li><li><a class="nounderline abstract_t">Goodman LJ, Trenholme GM, Kaplan RL, et al. Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults. Arch Intern Med 1990; 150:541.</a></li><li><a class="nounderline abstract_t">Geme JW 3rd, Hodes HL, Marcy SM, et al. Consensus: management of Salmonella infection in the first year of life. Pediatr Infect Dis J 1988; 7:615.</a></li><li><a class="nounderline abstract_t">Gökalp AS, Toksoy HB, Türkay S, et al. Intravenous immunoglobulin in the treatment of Salmonella typhimurium infections in preterm neonates. Clin Pediatr (Phila) 1994; 33:349.</a></li><li><a class="nounderline abstract_t">Elenga N, Cuadro E, Long L, et al. Salmonella enterica serovar Panama meningitis in exclusive breastfeeding infants: Report of 4 cases, clinical features and therapeutic challenges. Medicine (Baltimore) 2017; 96:e6665.</a></li><li class="breakAll">American Academy of Pediatrics. Salmonella infections. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, 2021. p.655.</li><li><a class="nounderline abstract_t">Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. Clin Infect Dis 2017; 65:e45.</a></li><li><a class="nounderline abstract_t">Wen SC, Best E, Nourse C. Non-typhoidal Salmonella infections in children: Review of literature and recommendations for management. J Paediatr Child Health 2017; 53:936.</a></li><li><a class="nounderline abstract_t">Benenson S, Raveh D, Schlesinger Y, et al. The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia. Am J Med 2001; 110:60.</a></li><li><a class="nounderline abstract_t">Cohen PS, O'Brien TF, Schoenbaum SC, Medeiros AA. The risk of endothelial infection in adults with salmonella bacteremia. Ann Intern Med 1978; 89:931.</a></li><li><a class="nounderline abstract_t">Gordon MA, Banda HT, Gondwe M, et al. Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 2002; 16:1633.</a></li><li><a class="nounderline abstract_t">Hung CC, Hsieh SM, Hsiao CF, et al. Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy. AIDS 2001; 15:645.</a></li><li><a class="nounderline abstract_t">Keddy KH, Takuva S, Musekiwa A, et al. An association between decreasing incidence of invasive non-typhoidal salmonellosis and increased use of antiretroviral therapy, Gauteng Province, South Africa, 2003-2013. PLoS One 2017; 12:e0173091.</a></li><li><a class="nounderline abstract_t">Gordon MA. Salmonella infections in immunocompromised adults. J Infect 2008; 56:413.</a></li><li><a class="nounderline abstract_t">Mori N, Szvalb AD, Adachi JA, et al. Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer. BMC Infect Dis 2021; 21:1021.</a></li><li class="breakAll">Clinicalinfo.HIV.gov. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/bacterial-enteric?view=full (Accessed on November 22, 2021).</li><li><a class="nounderline abstract_t">Buchwald DS, Blaser MJ. A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella. Rev Infect Dis 1984; 6:345.</a></li><li><a class="nounderline abstract_t">Torres Soto M, Hammond S, Elshaboury RH, et al. Recurrent Relatively Resistant Salmonella infantis Infection in 2 Immunocompromised Hosts Cleared With Prolonged Antibiotics and Fecal Microbiota Transplantation. Open Forum Infect Dis 2019; 6:ofy334.</a></li><li><a class="nounderline abstract_t">Piatek J, Sommermeyer H, Bernatek M, et al. Persistent infection by Salmonella enterica servovar Typhimurium: are synbiotics a therapeutic option? - a case report. Benef Microbes 2019; 10:211.</a></li><li><a class="nounderline abstract_t">Roberts C, Wilkins EG. Salmonella screening of pregnant women. J Hosp Infect 1987; 10:67.</a></li><li><a class="nounderline abstract_t">Citernesi A, Spinelli G, Piazzesi G, et al. [Screening for Salmonella in pregnancy]. Minerva Ginecol 1994; 46:681.</a></li><li><a class="nounderline abstract_t">Gyang A, Saunders M. Salmonella Mississippi: a rare cause of second trimester miscarriage. Arch Gynecol Obstet 2008; 277:437.</a></li><li><a class="nounderline abstract_t">Scialli AR, Rarick TL. Salmonella sepsis and second-trimester pregnancy loss. Obstet Gynecol 1992; 79:820.</a></li><li><a class="nounderline abstract_t">Coughlin LB, McGuigan J, Haddad NG, Mannion P. Salmonella sepsis and miscarriage. Clin Microbiol Infect 2003; 9:866.</a></li><li><a class="nounderline abstract_t">Rai B, Utekar T, Ray R. Preterm delivery and neonatal meningitis due to transplacental acquisition of non-typhoidal Salmonella serovar montevideo. BMJ Case Rep 2014; 2014.</a></li><li><a class="nounderline abstract_t">van der Klooster JM, Roelofs HJ. Management of Salmonella infections during pregnancy and puerperium. Neth J Med 1997; 51:83.</a></li><li><a class="nounderline abstract_t">Standaert SM, Hutcheson RH, Schaffner W. Nosocomial transmission of Salmonella gastroenteritis to laundry workers in a nursing home. Infect Control Hosp Epidemiol 1994; 15:22.</a></li><li><a class="nounderline abstract_t">Weikel CS, Guerrant RL. Nosocomial salmonellosis. Infect Control 1985; 6:218.</a></li><li><a class="nounderline abstract_t">Musher DM, Rubenstein AD. Permanent carriers of nontyphosa salmonellae. Arch Intern Med 1973; 132:869.</a></li><li><a class="nounderline abstract_t">Moritz ED, Ebrahim-Zadeh SD, Wittry B, et al. Foodborne Illness Outbreaks at Retail Food Establishments - National Environmental Assessment Reporting System, 25 State and Local Health Departments, 2017-2019. MMWR Surveill Summ 2023; 72:1.</a></li><li><a class="nounderline abstract_t">Tauxe RV, Hassan LF, Findeisen KO, et al. Salmonellosis in nurses: lack of transmission to patients. J Infect Dis 1988; 157:370.</a></li><li><a class="nounderline abstract_t">Dryden MS, Keyworth N, Gabb R, Stein K. Asymptomatic foodhandlers as the source of nosocomial salmonellosis. J Hosp Infect 1994; 28:195.</a></li><li><a class="nounderline abstract_t">Khuri-Bulos NA, Abu Khalaf M, Shehabi A, Shami K. Foodhandler-associated Salmonella outbreak in a university hospital despite routine surveillance cultures of kitchen employees. Infect Control Hosp Epidemiol 1994; 15:311.</a></li><li class="breakAll">Benenson AS. Control of Communicable Diseases Manual, 16th ed, American Public Health Association, Washington, DC 1995.</li><li><a class="nounderline abstract_t">Sirinavin S, Thavornnunth J, Sakchainanont B, et al. Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers. Clin Infect Dis 2003; 37:685.</a></li></ol></div><div id="topicVersionRevision">Topic 2697 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37384552" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Preliminary Incidence and Trends of Infections Caused by Pathogens Transmitted Commonly Through Food - Foodborne Diseases Active Surveillance Network, 10 U.S. Sites, 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28306338" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The Epidemiology of Childhood Salmonella Infections in Alberta, Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22283668" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : An outbreak of Salmonella serotype Typhimurium infections with an unusually long incubation period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15633679" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prolonged incubation period of salmonellosis associated with low bacterial doses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8119352" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Dose-response effects in an outbreak of Salmonella enteritidis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16096776" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Diagnostic value of bacterial stool cultures and viral antigen tests based on clinical manifestations of acute gastroenteritis in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13452006" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Clinical manifestations of salmonellosis in man; an evaluation of 7779 human infections identified at the New York Salmonella Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1597901" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : From the Centers for Disease Control. Outbreak of Salmonella enteritidis infection associated with consumption of raw shell eggs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15478071" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Quinolone resistance is associated with increased risk of invasive illness or death during infection with Salmonella serotype Typhimurium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15078589" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Salmonella enteritidis infections, United States, 1985-1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24617446" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Clinical outcomes of nalidixic acid, ceftriaxone, and multidrug-resistant nontyphoidal salmonella infections compared with pansusceptible infections in FoodNet sites, 2006-2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3306260" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Extra-intestinal manifestations of salmonella infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11419499" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Systemic nontyphoidal Salmonella infection in normal infants in Thailand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19222929" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The outcome of non-typhoidal salmonella meningitis in Malawian children, 1997-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8910753" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : An outbreak of Salmonella enteritidis in a maternity and neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7636145" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Nosocomial outbreak of Salmonella typhimurium infection in a nursery intensive care unit (NICU) and paediatric ward.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13207112" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Salmonella cholerae suis: a clinical and epidemiological evaluation of 329 infections identified between 1940 and 1954 in the New York Salmonella Center.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8909837" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Mycotic aneurysm due to non-typhi salmonella: report of 16 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4605105" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Septicemia with non-typhoid salmonella.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1274984" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Salmonella heidelberg enteritis and bacteremia. An epidemic on two pediatric wards.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15655779" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30487167" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Persistent Infection and Long-Term Carriage of Typhoidal and Nontyphoidal Salmonellae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25102908" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Evaluation of the Luminex xTAG Gastrointestinal Pathogen Panel and the Savyon Diagnostics Gastrointestinal Infection Panel for the detection of enteric pathogens in clinical samples.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27957599" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Evaluation of the BioFire FilmArray®GastrointestinalPanel in a Midwestern Academic Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36263712" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Management and Outcomes of Salmonella Gastroenteritis in the Era of Rapid Molecular Testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23152205" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Antimicrobials for treating symptomatic non-typhoidal Salmonella infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1616214" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26740515" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Persistent Infections by Nontyphoidal Salmonella in Humans: Epidemiology and Genetics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8268363" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8783703" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Empirical treatment of severe acute community-acquired gastroenteritis with ciprofloxacin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2178582" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3050857" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Consensus: management of Salmonella infection in the first year of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8200169" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Intravenous immunoglobulin in the treatment of Salmonella typhimurium infections in preterm neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28489741" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Salmonella enterica serovar Panama meningitis in exclusive breastfeeding infants: Report of 4 cases, clinical features and therapeutic challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28489741" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Salmonella enterica serovar Panama meningitis in exclusive breastfeeding infants: Report of 4 cases, clinical features and therapeutic challenges.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29053792" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : 2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28556448" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Non-typhoidal Salmonella infections in children: Review of literature and recommendations for management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11152867" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The risk of vascular infection in adult patients with nontyphi Salmonella bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/717990" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : The risk of endothelial infection in adults with salmonella bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12172085" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Non-typhoidal salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11317004" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28264046" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : An association between decreasing incidence of invasive non-typhoidal salmonellosis and increased use of antiretroviral therapy, Gauteng Province, South Africa, 2003-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18474400" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Salmonella infections in immunocompromised adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34587893" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34587893" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6377442" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : A review of human salmonellosis: II. Duration of excretion following infection with nontyphi Salmonella.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30648128" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Recurrent Relatively Resistant Salmonella infantis Infection in 2 Immunocompromised Hosts Cleared With Prolonged Antibiotics and Fecal Microbiota Transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30574800" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Persistent infection by Salmonella enterica servovar Typhimurium: are synbiotics a therapeutic option? - a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2888814" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Salmonella screening of pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7885614" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : [Screening for Salmonella in pregnancy].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18004579" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Salmonella Mississippi: a rare cause of second trimester miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1565377" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Salmonella sepsis and second-trimester pregnancy loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14616710" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Salmonella sepsis and miscarriage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24876215" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Preterm delivery and neonatal meningitis due to transplacental acquisition of non-typhoidal Salmonella serovar montevideo.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9286145" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Management of Salmonella infections during pregnancy and puerperium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8133005" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Nosocomial transmission of Salmonella gastroenteritis to laundry workers in a nursing home.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3894270" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Nosocomial salmonellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4757259" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Permanent carriers of nontyphosa salmonellae.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37252900" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Foodborne Illness Outbreaks at Retail Food Establishments - National Environmental Assessment Reporting System, 25 State and Local Health Departments, 2017-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3335812" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Salmonellosis in nurses: lack of transmission to patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7852733" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Asymptomatic foodhandlers as the source of nosocomial salmonellosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8077642" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Foodhandler-associated Salmonella outbreak in a university hospital despite routine surveillance cultures of kitchen employees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8077642" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Foodhandler-associated Salmonella outbreak in a university hospital despite routine surveillance cultures of kitchen employees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12942401" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Norfloxacin and azithromycin for treatment of nontyphoidal salmonella carriers.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
